Skip to main content

Table 1 Patient demographics

From: Neural versus pneumatic control of pressure support in patients with chronic obstructive pulmonary diseases at different levels of positive end expiratory pressure: a physiological study

Patient Gender Diagnosis APACHE II Days on MV FiO2 CRS RRS PEEPiSTAT FEV1
      % ml/cm H2O cm H2O/l/s cm H2O % predicted
1 M AECOPD, pneumonia, type 2 respiratory failure, pulmonary encephalopathy 32 5 40 33 19 6 56
2 M AECOPD, pneumonia, type 2 respiratory failure 33 6 40 43 15 8 48
3 M AECOPD, pneumonia, type 2 respiratory failure, septic shock 22 4 40 40 16 6 62
4 M AECOPD, pneumonia, type 2 respiratory failure, pulmonary encephalopathy 34 4 40 42 18 5 41
5 M AECOPD, pneumonia, type 2 respiratory failure, pulmonary encephalopathy 35 3 40 30 16 5 58
6 M AECOPD, pneumonia, type 2 respiratory failure, pulmonary encephalopathy 33 2 40 26 16 6 55
7 M AECOPD, pneumonia, type 2 respiratory failure, pulmonary encephalopathy 31 5 40 27 21 5 38
8 F AECOPD, pneumonia, type 2 respiratory failure, pulmonary encephalopathy 32 5 40 31 27 5 47
9 M AECOPD, pneumonia, type 2 respiratory failure, septic shock 42 8 40 42 23 5 46
10 M AECOPD, pneumonia, type 2 respiratory failure, pulmonary encephalopathy 30 1 40 40 26 5 50
11 F AECOPD, pneumonia, type 2 respiratory failure, pulmonary encephalopathy 31 2 40 23 24 6 37
12 F AECOPD, pneumonia, type 2 respiratory failure, pulmonary encephalopathy 34 1 50 20 17 8 44
Mean    32.4 3.8 40.8 33.1 19.8 5.8 48.5
SD    4.5 2.1 2.9 8.1 4.2 1.1 8.0
  1. APACHE acute physiology and chronic health evaluation, AECOPD acute exacerbation of chronic obstructive pulmonary disease, MV mechanical ventilation, CRS compliance of respiratory system, RRS resistance of respiratory system, PEEPiSTAT static intrinsic positive end expiratory pressure, FEV1 forced expiratory volume in one second